IWC
VVOS icon

Integrated Wealth Concepts’s Vivos Therapeutics VVOS Stock Holding History

Integrated Wealth Concepts’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144 Buy
+320
New +$251 ﹤0.01% 5774

Other funds holding VVOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Integrated Wealth Concepts's VVOS Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Vivos Therapeutics (VVOS) in Q2 2026: 320 shares worth $144. The stake represents ﹤0.01% of the portfolio and ranks #5774 among its holdings.

23 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

  • Integrated Wealth Concepts held 320 shares of Vivos Therapeutics worth $144 as of Q2 2026.
  • Vivos Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Vivos Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5774 holding.
  • 23 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.